Widening spectrum of neuroleptic malignant syndrome: Case series

Neuroleptic malignant syndrome (NMS) is a rare and rapidly progressive syndrome with mortality rate of 5.6%. The spectrum of onset, progression and outcome is heterogeneous and is associated with number of risk factors. In our case series, we entail the triggers, hospital course and outcome of five...

Descripción completa

Detalles Bibliográficos
Autores principales: Paul, Gunchan, Singhal, Sachi, Paul, Birinder S., Singh, Gurparvesh, Goyal, Shriya
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Wolters Kluwer - Medknow 2022
Materias:
Forum
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9511852/
https://www.ncbi.nlm.nih.gov/pubmed/36171930
http://dx.doi.org/10.4103/joacp.JOACP_8_21

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9511852/
https://www.ncbi.nlm.nih.gov/pubmed/36171930
http://dx.doi.org/10.4103/joacp.JOACP_8_21

Ejemplares similares